Schedule 13G ownership disclosure

Y-MABS THERAPEUTICS INC

Security class unavailable · CUSIP: 984241109

Event date: 2023-03-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
977,142
Percent of class
2.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-002445
Form type
SC 13G
Filer
ACORN BIOVENTURES, L.P.
CIK
CIK 1766853
Filed
Apr 03, 2023
Reporting period
Mar 15, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub